<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03541473</url>
  </required_header>
  <id_info>
    <org_study_id>17.20.BIO</org_study_id>
    <nct_id>NCT03541473</nct_id>
  </id_info>
  <brief_title>Phosphate Metabolites in Brain of Humans Aged 50+</brief_title>
  <official_title>Assessment of Nutrition on Brain Energy Metabolism in Humans Aged 50+: Measurement of Phosphate Metabolites by 31P-MRS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ecole Polytechnique Fédérale de Lausanne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this research project is to determine in elderly subjects (&gt;50 year old) by
      31P-MRS the brain concentration of phosphorous metabolites species and fluxes, before and
      after consumption of 2 commercially available oral nutrition products
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 14, 2018</start_date>
  <completion_date type="Actual">October 19, 2018</completion_date>
  <primary_completion_date type="Actual">October 19, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change in brain NAD+/NADH ratio (RX) after the intake of the nutrition products</measure>
    <time_frame>31P metabolites and fluxes will be measured during one hour 2 times, one before product intake (control) and the second one 45 min after product intake&quot;</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Basic Science</condition>
  <arm_group>
    <arm_group_label>Peptamen® 1.5 Vanilla</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Boost Plus® Vanilla</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Peptamen® 1.5 Vanilla</intervention_name>
    <description>Nutritionally complete formula with 10g MCT in 250 mL, commercially available</description>
    <arm_group_label>Peptamen® 1.5 Vanilla</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Boost Plus® Vanilla</intervention_name>
    <description>Product of same nutritional composition but without MCT</description>
    <arm_group_label>Boost Plus® Vanilla</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women aged between 50 and 75 years

          -  Healthy, based on the medical screening visit

          -  Normal BMI for age (18.5-29.9 kg/m2)

          -  Able to understand and to sign a written informed consent prior to trial entry

          -  Informed consent signed

        Exclusion Criteria:

          -  Known type 1 or type 2 diabetes, on anamnesis

          -  Family history of type 2 diabetes (parents)

          -  Any other metabolic disease possibly impacting the postprandial glucose and insulin
             response (on anamnesis, to the opinion of the medical expert)

          -  Malabsorptive disorders including but not limited to pancreatitis, Crohn's disease,
             etc, to the opinion of the medical expert

          -  Any ongoing medication impacting dietary fat absorption and metabolism like statins,
             bile acid sequestrants, lipid lowering medications, or fibrates , to the opinion of
             the medical expert

          -  Any ongoing medication impacting the postprandial glucose and insulin response (like
             beta blockers), to the opinion of the medical expert

          -  Any ongoing medication impacting brain metabolism or function (neuroleptics,
             antidepressants, anti-epileptics), to the opinion of the medical expert

          -  Ongoing chemotherapy

          -  Any food supplement intake (e.g. MCT, ketone salts = Calcium, Sodium, Potassium,
             Magnesium) or special diet (e.g. ketogenic diet) possibly impacting basal ketone
             levels, to the opinion of the medical expert.

          -  Claustrophobia

          -  Hearing disorders (the participant placed into the MRS tunnel should be able to hear
             from the operators, for safety purpose)

          -  Having any metallic, electronic, magnetic, or mechanical implants, devices, or
             objects, for safety reason linked to magnetic field exposure (MRS):

               -  Aneurysm clip(s)

               -  Cardiac pacemaker

               -  Implanted cardioverter defibrillator (ICD)

               -  Electronic implant or device

               -  Magnetically-activated implant or device

               -  Neurostimulation system

               -  Spinal cord stimulator

               -  Cochlear implant or implanted hearing aid

               -  Insulin or infusion pump

               -  Implanted drug infusion device, like portacath® for instance

               -  Any type of prosthesis or implant

               -  Artificial or prosthetic limb

               -  Any metallic fragment or foreign body

               -  Hearing aid

               -  Other implant

          -  Subject injured by a metallic object or foreign body

          -  Allergy to cow milk or soy proteins

          -  Currently participating or having participated in an investigational trial during the
             past month

          -  Subjects not willing and/or not able to comply with scheduled visits and the
             requirements of the research protocol.

          -  Subject having a hierarchical link with the investigator or co-investigators.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>École Polytechnique Fédérale de Lausanne (EPFL) / Center for Biomedical Imaging (CIBM)</name>
      <address>
        <city>Lausanne</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>May 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>December 4, 2018</last_update_submitted>
  <last_update_submitted_qc>December 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

